Please wait...
About This Project
OncoSynergy, Inc.
The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
Recent Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Does insecticide exposure affect solitary bee nesting behavior?
Alfalfa leafcutter bees (ALBs) are important crop pollinators that nest in aboveground cavities (e.g. straws...
Creating a neural network that classifies Dinoflagellate species
I think we have the technology to develop an artificial intelligence model that can differentiate between...
Join the Journey: Golden-winged Warbler Migration
Donate to our U Maine gift account. Golden-winged Warbler is one of North America's fastest declining forest...
